Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (211-220 of 551) with videos related to

Pageof 56
Sort By:
Bioorganic & Medicinal Chemistry|September 8, 2000
Syntheses and biological activity of C-3'-difluoromethyl-taxoidsI Ojima, S Lin, J C Slater, et al.
British Journal of Cancer|December 6, 2000
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitorsC Ferlini, M Distefano, F Pignatelli, et al.
Cancer Letters|September 4, 1995
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS)G Ferrandina, F O Ranelletti, G Scambia, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 2, 2004
Sonographic features of decidualized ovarian endometriosis suspicious for malignancyE Fruscella, A C Testa, G Ferrandina, et al.
British Journal of Cancer|July 1, 1990
Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignanciesG Scambia, P Benedetti Panici, L Perrone, et al.
European Journal of Gynaecological Oncology|January 1, 1987
Squamous cervical cancer at stage IB and II: a ten years experience, analysis of 231 casesP Benedetti Panici, P F Di Roberto, S Greggi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 20, 2022
Influence of uterine manipulator on oncological outcome in minimally invasive surgery of endometrial cancer: A systematic review and meta-analysisG Scutiero, G Vizzielli, C Taliento, et al.
British Journal of Cancer|October 2, 2003
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancerG D'Agostino, G Ferrandina, M Ludovisi, et al.
Oncology Research|June 13, 2000
Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127C Ferlini, M Distefano, L Pierelli, et al.
Cancer|September 26, 2001
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapyG Cantuaria, A Fagotti, G Ferrandina, et al.
Pageof 56

Showing results (211-220 of 551) with videos related to

Sort By:
Pageof 56
Bioorganic & Medicinal Chemistry|September 8, 2000
Syntheses and biological activity of C-3'-difluoromethyl-taxoidsI Ojima, S Lin, J C Slater, et al.
British Journal of Cancer|December 6, 2000
Antitumour activity of novel taxanes that act at the same time as cytotoxic agents and P-glycoprotein inhibitorsC Ferlini, M Distefano, F Pignatelli, et al.
Cancer Letters|September 4, 1995
Interaction of tamoxifen with cytosolic and nuclear type II estrogen binding sites (type II EBS)G Ferrandina, F O Ranelletti, G Scambia, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|October 2, 2004
Sonographic features of decidualized ovarian endometriosis suspicious for malignancyE Fruscella, A C Testa, G Ferrandina, et al.
British Journal of Cancer|July 1, 1990
Serum levels of tumour associated glycoprotein (TAG 72) in patients with gynaecological malignanciesG Scambia, P Benedetti Panici, L Perrone, et al.
European Journal of Gynaecological Oncology|January 1, 1987
Squamous cervical cancer at stage IB and II: a ten years experience, analysis of 231 casesP Benedetti Panici, P F Di Roberto, S Greggi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 20, 2022
Influence of uterine manipulator on oncological outcome in minimally invasive surgery of endometrial cancer: A systematic review and meta-analysisG Scutiero, G Vizzielli, C Taliento, et al.
British Journal of Cancer|October 2, 2003
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancerG D'Agostino, G Ferrandina, M Ludovisi, et al.
Oncology Research|June 13, 2000
Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127C Ferlini, M Distefano, L Pierelli, et al.
Cancer|September 26, 2001
GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapyG Cantuaria, A Fagotti, G Ferrandina, et al.
Pageof 56